ILiAD Biotechnologies
Quick facts
Phase 2 pipeline
- BPZE1 pertussis vaccine and Boostrix · Immunology
BPZE1 is a live attenuated pertussis vaccine designed to induce mucosal and systemic immunity against Bordetella pertussis, while Boostrix is a combined acellular pertussis booster vaccine.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: